医薬品ドラッグデリバリー市場 - 2031年の成長予測、統計および事実

  • Report Code : TIPRE00007628
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 197
Buy Now

医薬品のドラッグデリバリー市場は、2019 年の 1,403,082.9 百万米ドルから、2027 年には 2,296,170.9 百万米ドルに達すると予想されています。市場は、2020 年から 2027 年にかけて 6.6% の CAGR で成長すると推定されています

薬物送達システムは、さまざまな病気の治療や患者の健康の改善を目的として、さまざまな治療薬を制御または標的に送達するために主に使用されるテクノロジーです。ドラッグデリバリーシステムは、薬物や化学物質を体内に注入するために使用される医療機器です。市場で入手可能な薬物送達システムには、経粘膜、経口、肺、注射、局所、鼻、埋め込み、眼などがあります。

医薬品配送における収益性の高い地域市場

市場に関する洞察

感染症および慢性疾患の蔓延

感染症、特に細菌性疾患の蔓延は、世界中で継続的に増加しています。 2019年に米国微生物学会が発表した研究によると、カルバペネム耐性腸内細菌科によって毎年約150~450万件の感染が引き起こされていると世界が報告しています。さらに、このグループの細菌は、米国で毎年約 49,000 人の入院を引き起こしています。さらに、ユニセフが発表した研究によると、2018年には肺炎により5歳未満の子どもが約1,755,000人死亡した。また、この地域で約 120 万人の子供たちが下痢によって命を落としました。このように指数関数的に増加する感染症の蔓延により、医薬品の消費が促進され、最終的には医薬品のドラッグデリバリー市場の成長を促進します。

慢性疾患の中でも、がんと糖尿病が慢性疾患の主な原因となっています。世界中の死亡率。たとえば、米国癌協会 (ACS) が実施した調査によると、米国では 2018 年に約 1,735,350 人の新たな癌症例が報告されました。さらに、国際糖尿病連盟 (IDF) によると、2017 年には約 4,600 万人のアメリカ人が糖尿病に苦しんでいました。 、この数は 2045 年までに 6,200 万人に達すると予想されています。また、2017 年には世界中で約 4 億 2,500 万人が糖尿病を抱えており、その数は 2045 年までに 6 億 2,900 万人に達すると予想されているとも述べられています。

投与経路に関する洞察

医薬品ドラッグデリバリー市場は、投与経路別に、経口ドラッグデリバリー、注射ドラッグデリバリー、局所ドラッグデリバリー、眼への薬物送達、肺への薬物送達、鼻への薬物送達、経粘膜への薬物送達、および埋め込み型薬物送達。 2019 年には、注射可能なドラッグデリバリーセグメントが市場で最大のシェアを占めました。しかし、局所ドラッグデリバリーセグメントは、予測期間中に市場で最も高い CAGR を記録すると予想されます。

医薬品のドラッグデリバリー市場、投与経路別 - 2019 年と 2027 年

アプリケーション インサイト

アプリケーションに基づいて、医薬品ドラッグ デリバリー市場は感染症、がん、心血管疾患、糖尿病に分類されています。 、呼吸器疾患、中枢神経系疾患、自己免疫疾患、その他の疾患。 2019年にはがんセグメントが市場で最大のシェアを占めた。ただし、感染症セグメントは、予測期間中に最も高い CAGR を記録すると推定されています。

エンド ユーザー インサイト

エンド ユーザーに基づく、医薬品のドラッグデリバリー市場は、病院、在宅医療環境、ASC/クリニック、およびその他のエンドユーザーに分割されています。 2019 年には病院部門が市場で最大のシェアを占めましたが、在宅医療部門は 2020 年から 2027 年にかけて最高の CAGR を記録すると推定されています。

戦略的洞察< /h3>

製品の発売と承認は、世界中で事業展開を拡大し、増大する需要に対応するために企業が一般的に採用する戦略です。この戦略は、市場プレーヤーが対応する製品ポートフォリオを拡大するために最も一般的に採用しています。

医薬品ドラッグデリバリー市場で事業を展開しているプレーヤーは、顧客ベースを拡大するために拡大戦略を採用しています。世界中で。また、コラボレーションや製品発売の戦略も実行します。これらの戦略により、同社は世界的にブランド名を維持することができます。たとえば、2018年5月、グラクソ・スミスクライン社は、5歳未満の小児の喘息の維持治療におけるアルニュイティ・エリプタ(フロ酸フルチカゾン)の使用についてFDAの承認を取得しました。これは、1 日 1 回投与の吸入コルチコステロイド (ICS) 薬です。

投与経路別

  • 経口薬物送達
  • 注射による薬物送達
  • 局所的な薬物送達
  • 眼への薬物送達
  • 肺への薬物送達
  • 鼻への薬物送達
  • 経粘膜薬物送達
  • 埋め込み型薬物送達

用途別

  • 感染症
  • がん< /li>
  • 心血管疾患
  • 糖尿病
  • 呼吸器疾患
  • 中枢神経系疾患
  • 自己免疫疾患
  • < li>その他のアプリケーション

エンドユーザー別

  • 病院
  • 在宅医療環境
  • ASC/クリニック< /li>
  • その他のエンド ユーザー

地理別

  • 北米
    • 米国
    • カナダ< /li>
    • メキシコ
  • ヨーロッパ
    • ドイツ
    • イギリス
    • フランス
    • イタリア
    • スペイン
  • アジア太平洋 (APAC)
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
  • 中東およびアフリカ (MEA)
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
  • 南中米 (SCAM)
    • ブラジル
    • アルゼンチン

会社概要

  • ファイザー株式会社
  • バイエル AG
  • ジョンソン&amp; Johnson Services, Inc.
  • Novartis AG
  • 3M
  • Becton, Dickinson and Company
  • サノフィ
  • メルクKGaA
  • グラクソ・スミスクライン plc.
  • アンタレス ファーマ
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What does pharmaceutical drug delivery mean?

Drug delivery systems are medical devices used to inject drugs or chemicals into the body. Some of the drug delivery systems available in the market include, transmucosal, oral, pulmonary, injectable, topical, nasal, implantable, and ocular among others. Drug delivery systems are the technologies primarily used for the controlled or targeted delivery of various therapeutic agents to treat various diseases or improve the health of the patients.

What are the driving and restraining factors for the pharmaceutical drug delivery market across the globe?

The growth of the market is attributed to some key driving factors such as growing prevalence of infectious and increasing r&d spending for drug delivery devices. However, high cost of drug delivery device development is likely to pose a negative impact on the market during the forecast years.

What is the regional analysis in terms of pharmaceutical drug delivery?

The North American region holds the largest market for the pharmaceutical drug delivery. The United States held the largest market for pharmaceutical drug delivery mean market and is expected to grow due to factors such as increasing incidence of cancer along with the growing need for diagnosing, demand for chronic disease medications from pharmaceutical companies, presence of key market players and extensive R&D conducted by various academic and research institutes.

The List of Companies - Pharmaceutical Drug Delivery Market

  1. Pfizer Inc.
  2. Bayer AG
  3. Johnson & Johnson Services, Inc.
  4. Novartis AG
  5. 3M
  6. Becton, Dickinson and Company
  7. Sanofi
  8. MERCK KGaA
  9. GlaxoSmithKline plc.
  10. Antares Pharma

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports